A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. I: Contraceptive efficacy and side effects
Contraception (Stoneham) 37(1): 1-20
1988
ISSN/ISBN: 0010-7824 Document Number: 372013
Document emailed within 1 workday
Related Documents
Ziaei, S.; Rajaei, L.; Faghihzadeh, S.; Lamyian, M. 2002: Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route Contraception 65(5): 329-331Ziaei, S.; Rajaei, L.; Faghihzadeh, S.; Lamyian, M. 2002: Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route Contraception 65(5): 329-331
Duijkers, I.; Killick, S.; Bigrigg, A.; Dieben, T.O.M. 2004: A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 9(3): 131-140
Engman, J.; Sundström Poromaa, I.; Moby, L.; Wikström, J.; Fredrikson, M.; Gingnell, M. 2018: Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 43(3): 555-563
Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Misro, M.M.; Chaki, S.P.; Kaushik, M.C.; Nandan, D. 2009: Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats Contraception 79(6): 488-497
Thamkhantho, M.; Chayachinda, C.; Plubprasit, J. 2020: Preliminary Report on Comparative Study of Side Effects of Progestin-Only Contraceptive Methods between Thai Women Using DMPA and a Single-Rod Sub-Dermal Implant at Siriraj Hospital, Bangkok, Thailand Journal of the Medical Association of Thailand 103(7): 680-685
Thamkhantho, M.; Chayachinda, C.; Plubprasit, J. 2020: Preliminary Report on Comparative Study of Side Effects of Progestin-Only Contraceptive Methods between Thai Women Using DMPA and a Single-Rod Sub-Dermal Implant at Siriraj Hospital, Bangkok, Thailand Journal of the Medical Association of Thailand 103(7): 680-685
Rákóczi, I.; Gerö, G.; Demeter, J.; Gáti, I. 1985: Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance Arzneimittel-Forschung 35(3): 630-633
London, R.S.; Chapdelaine, A.; Upmalis, D.; Olson, W.; Smith, J. 1992: Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive Acta Obstetricia et Gynecologica Scandinavica. Suppl 156: 9-14
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Boonyarangkul, A.; Taneepanichskul, S. 2007: Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years Journal of the Medical Association of Thailand 90(9): 1715-1719
De Sampaio Júnior, L.F.; Dib, J.E.; Pereira, V.M.; Neme, B. 1971: Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic Maternidade e Infancia; Arquivos Medicos-Sociais 30(1): 65-69
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Kaunitz, A.M.; Darney, P.D.; Ross, D.; Wolter, K.D.; Speroff, L. 2009: Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density Contraception 80(1): 7-17
Kaunitz, A.M.; Darney, P.D.; Ross, D.; Wolter, K.D.; Speroff, L. 2009: Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density Contraception 80(1): 7-17
Yao, X.-y.; Du, M.-k. 2003: A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant Zhonghua Fu Chan Ke Za Zhi 38(7): 419-422